Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HAPN
3151
Happen Inc
HAPN
$2.11B
| $440K | ﹤0.01% |
21,285
-704,731
| -97% | -$17.5M |
|
3152
Vanguard Tax-Exempt Bond Index Fund
VTEB
$45.8B
| $440K | ﹤0.01% |
+8,507
| New | +$439K |
|
3153
BlackRock Debt Strategies Fund
DSU
$593M
| $438K | ﹤0.01% |
37,428
-1,017
| -3% | -$11.9K |
|
|
CSRA
3154
DELISTED
CSRA Inc.
CSRA
| $438K | ﹤0.01% |
14,641
-915,899
| -98% | -$27.7M |
|
3155
INNOVATE Corp
VATE
$105M
| $436K | ﹤0.01% |
7,330
+6,040
| +468% | +$325K |
|
|
SPNE
3156
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $436K | ﹤0.01% |
43,079
-44,752
| -51% | -$459K |
|
3157
NewMarket
NEU
$8.56B
| $435K | ﹤0.01% |
1,094
-4,775
| -81% | -$1.93M |
|
3158
American Coastal Insurance
ACIC
$444M
| $434K | ﹤0.01% |
+25,185
| New | +$409K |
|
3159
PUT
eHealth
EHTH
$38.4M
| $434K | ﹤0.01% |
+25,000
| New | +$559K |
|
|
CLCT
3160
DELISTED
Collectors Universe
CLCT
| $433K | ﹤0.01% |
15,106
-40,889
| -73% | -$1.1M |
|
3161
Iridium Communications
IRDM
$4.99B
| $432K | ﹤0.01% |
+36,643
| New | +$424K |
|
3162
Ormat Technologies
ORA
$6.53B
| $432K | ﹤0.01% |
6,756
-28,444
| -81% | -$1.8M |
|
|
AMPE
3163
PUT
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $432K | ﹤0.01% |
+354
| New | +$166K |
|
|
ZEAL
3164
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
| $432K | ﹤0.01% |
31,752
-38,213
| -55% | -$600K |
|
3165
Assured Guaranty
AGO
$3.3B
| $430K | ﹤0.01% |
12,695
-48,377
| -79% | -$1.75M |
|
3166
Hennessy Advisors
HNNA
$78.4M
| $430K | ﹤0.01% |
26,019
-30,229
| -54% | -$497K |
|
3167
Allegiant Air
ALGT
$2.25B
| $429K | ﹤0.01% |
2,769
-12,460
| -82% | -$1.76M |
|
3168
H&R Block
HRB
$6.56B
| $427K | ﹤0.01% |
16,282
-314,133
| -95% | -$8.15M |
|
3169
Jakks Pacific
JAKK
$299M
| $427K | ﹤0.01% |
18,149
-3,035
| -14% | -$84.2K |
|
3170
UroGen Pharma
URGN
$2.27B
| $427K | ﹤0.01% |
+11,485
| New | +$409K |
|
|
BOBE
3171
DELISTED
Bob Evans Farms, Inc.
BOBE
| $424K | ﹤0.01% |
5,378
-57,806
| -91% | -$4.49M |
|
|
ATCO
3172
DELISTED
Atlas Corp.
ATCO
| $421K | ﹤0.01% |
62,436
-115,948
| -65% | -$757K |
|
3173
American Public Education
APEI
$846M
| $420K | ﹤0.01% |
16,760
-8,265
| -33% | -$193K |
|
3174
Theravance Biopharma
TBPH
$884M
| $419K | ﹤0.01% |
+15,038
| New | +$445K |
|
3175
US Physical Therapy
USPH
$1.15B
| $419K | ﹤0.01% |
5,805
-22,468
| -79% | -$1.53M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.